National Osteoporosis Society – incidence of fractures in the UK.
Innovative Medicines Initiative (collaboration of EU and Pharmaceutical Industry) – GETREAL: clinical effectiveness in drug development.
Wellcome Trust - Randomisation within the database: a feasibility trial evaluating the comparative effects of statins in a research network of general practices (RETRO-PRO).
National Institute for Health Research, Health Technology Assessment Programme -Antibiotics for exacerbations of chronic obstructive pulmonary disease: a randomised clinical trial within the General Practice Research Database.
NIHR- HTA, Real-time evaluation and refinement of tools and criteria used in primary care to aid hospital referral decisions for patients of all ages during an influenza pandemic.
Wellcome Trust - Pharmacogenetics of statin-induced muscle toxicity: exploration using the UK General Practice Research Database.
Wellcome Trust - Cluster Randomised Trials in a primary care database: utilising electronic patient records for intervention research.
Wellcome Trust - Influences on psychosocial and physical health in early adulthood: phenotypic enrichment of the ALSPAC cohort through linkage to primary care electronic patient records and other databases.
Department of Health. An investigation of the effects of long term exposure to air pollution on cardiorespiratory morbidity and mortality in a large population cohort.
Medical Research Council - Role of primary care in translating effective lifestyle modification strategies.
Innovative Medicines Initiative (collaboration of EU and Pharmaceutical Industry) - Pharmacological Research on Outcomes of Therapeutics by a European Consortium (PROTECT).
FP-7 EU funding - Translational Research and Patient Safety in Europe (TRANSFORM).
Technology Strategy Board. Visualisation of the Quality of Electronic Health Records for Clinical Research.
Medical Research Council - Investigation of the association between traffic pollution and various health and physiological effects in London.
Innovative Medicines Initiative (collaboration of EU and Pharmaceutical Industry) PROTECT - To improve the phenotyping of outcomes (case definitions) for key adverse events with sufficient validity that can be used to for future pharmacogenetic studies in EHR databases.
Department of Health – Research Capability Program. Randomisation techniques and fraud detection in Randomised Evaluations of Accepted Choices in Treatment (REACT) trials.
Arthritis Research UK. Musculoskeletal health and extending working life.